Tel: +8615172508891     E-mail: znobio@qq.com
Sitemap

Zenuo Biotech

20 years of leading pharmaceutical ingredient supplier

Zeno Blog
Zeno Blog

17-Methyltestosterone SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name methyltestosterone

1.2 Other means of identification

Product number -

Other names Metrone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.

Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -

Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

2.Hazard identification

2.1 Classification of the substance or mixture

Carcinogenicity, Category 1B

Reproductive toxicity, Category 2

2.2 GHS label elements, including precautionary statements

Pictogram(s)

Signal word

Danger

Hazard statement(s)

H350 May cause cancer

H361 Suspected of damaging fertility or the unborn child

Precautionary statement(s)

Prevention

P201 Obtain special instructions before use.

P202 Do not handle until all safety precautions have been read and understood.

P280 Wear protective gloves/protective clothing/eye protection/face protection.

Response

P308+P313 IF exposed or concerned: Get medical advice/ attention.

Storage

P405 Store locked up.

Disposal

P501 Dispose of contents/container to ...

2.3 Other hazards which do not result in classificationnone

3.Composition/information on ingredients

3.1 Substances

Chemical name Common names and synonyms CAS number EC number Concentration

methyltestosterone methyltestosterone 58-18-4 none 100%

4.First-aid measures

4.1 Description of necessary first-aid measures

General advice

Consult a physician. Show this safety data sheet to the doctor in attendance.


If inhaled

If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.


In case of skin contact

Wash off with soap and plenty of water. Consult a physician.


In case of eye contact

Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.


If swallowed

Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.


4.2 Most important symptoms/effects, acute and delayed

no data available


4.3 Indication of immediate medical attention and special treatment needed, if necessary

Basic treatment: Establish a patent airway. Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with normal saline during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 ml/kg up to 200 ml of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover skin burns with dry sterile dressings after decontamination ... . /Poison A and B/


5.Fire-fighting measures

5.1 Extinguishing media

Suitable extinguishing media

Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.


5.2 Specific hazards arising from the chemical

no data available


5.3 Special protective actions for fire-fighters

Wear self-contained breathing apparatus for firefighting if necessary.


6.Accidental release measures

6.1 Personal precautions, protective equipment and emergency procedures

Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust. For personal protection see section 8.


6.2 Environmental precautions

Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided.


6.3 Methods and materials for containment and cleaning up

Pick up and arrange disposal. Sweep up and shovel. Keep in suitable, closed containers for disposal.


7.Handling and storage

7.1 Precautions for safe handling

Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Avoid exposure - obtain special instructions before use.Provide appropriate exhaust ventilation at places where dust is formed. For precautions see section 2.2.


7.2 Conditions for safe storage, including any incompatibilities

Commercially available preparations of methyltestosterone should be protected from light and stored in well-closed containers at a temperature less than 40°C, preferably between 2-30°C, unless otherwise specified by the manufacturer.


8.Exposure controls/personal protection

8.1 Control parameters

Occupational Exposure limit values

no data available


Biological limit values

no data available


8.2 Appropriate engineering controls

Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday.


8.3 Individual protection measures, such as personal protective equipment (PPE)

Eye/face protection

Safety glasses with side-shields conforming to EN166. Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).


Skin protection

Wear impervious clothing. The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace. Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique(without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands. The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and the standard EN 374 derived from it.


Respiratory protection

Wear dust mask when handling large quantities.


Thermal hazards

no data available


9.Physical and chemical properties

Physical state White to Off-White Crystalline Powder

Colour Crystals from hexane

Odour Odorless

Melting point/ freezing point 162-168oC

Boiling point or initial boiling point and boiling range 104-116oC(1 torr)

Flammability no data available

Lower and upper explosion limit / flammability limit no data available

Flash point 185.3oC

Auto-ignition temperature no data available

Decomposition temperature no data available

pH no data available

Kinematic viscosity no data available

Solubility no data available

Partition coefficient n-octanol/water (log value) no data available

Vapour pressure 1.8X10-8 mm Hg at 25°C (est)

Density and/or relative density no data available

Relative vapour density no data available

Particle characteristics no data available

10.Stability and reactivity

10.1 Reactivity

no data available


10.2 Chemical stability

Affected by light


10.3 Possibility of hazardous reactions

no data available


10.4 Conditions to avoid

no data available


10.5 Incompatible materials

no data available


10.6 Hazardous decomposition products

no data available


11.Toxicological information

Acute toxicity

Oral: no data available

Inhalation: no data available

Dermal: no data available

Skin corrosion/irritation

no data available


Serious eye damage/irritation

no data available


Respiratory or skin sensitization

no data available


Germ cell mutagenicity

no data available


Carcinogenicity

no data available


Reproductive toxicity

no data available


STOT-single exposure

no data available


STOT-repeated exposure

no data available


Aspiration hazard

no data available


12.Ecological information

12.1 Toxicity

Toxicity to fish: no data available

Toxicity to daphnia and other aquatic invertebrates: no data available

Toxicity to algae: no data available

Toxicity to microorganisms: no data available

12.2 Persistence and degradability

no data available


12.3 Bioaccumulative potential

An estimated BCF of 77 was calculated for 17-methyltestosterone(SRC), using a log Kow of 3.36(1) and a regression-derived equation(2). According to a classification scheme(3), this BCF suggests the potential for bioconcentration in aquatic organisms is moderate(SRC), provided the compound is not metabolized by the organism(SRC).


12.4 Mobility in soil

The Koc of 17-methyltestosterone is estimated as 1,600(SRC), using a log Kow of 3.36(1) and a regression-derived equation(2). According to a classification scheme(3), this estimated Koc value suggests that 17-methyltestosterone is expected to have low mobility in soil.


12.5 Other adverse effects

no data available


13.Disposal considerations

13.1 Disposal methods

Product

The material can be disposed of by removal to a licensed chemical destruction plant or by controlled incineration with flue gas scrubbing. Do not contaminate water, foodstuffs, feed or seed by storage or disposal. Do not discharge to sewer systems.


Contaminated packaging

Containers can be triply rinsed (or equivalent) and offered for recycling or reconditioning. Alternatively, the packaging can be punctured to make it unusable for other purposes and then be disposed of in a sanitary landfill. Controlled incineration with flue gas scrubbing is possible for combustible packaging materials.


14.Transport information

14.1 UN Number

ADR/RID: UN3249 IMDG: UN3249 IATA: UN3249

14.2 UN Proper Shipping Name

ADR/RID: MEDICINE, SOLID, TOXIC, N.O.S.

IMDG: MEDICINE, SOLID, TOXIC, N.O.S.

IATA: MEDICINE, SOLID, TOXIC, N.O.S.

14.3 Transport hazard class(es)

ADR/RID: 6.1(b) IMDG: 6.1(b) IATA: 6.1(b)

14.4 Packing group, if applicable

ADR/RID: III IMDG: III IATA: III

14.5 Environmental hazards

ADR/RID: no IMDG: no IATA: no

14.6 Special precautions for user


Prev: Synthesis and preliminary in vitro biological evaluation of 7α-testosterone-chlorambucil hybrid desi

Next: Brief Description of Nandrolone 434-22-0 SDS